Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Depreciation & Amortization (CF) (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Depreciation & Amortization (CF) data on record, last reported at $4.3 million in Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 52.93% year-over-year to $4.3 million; the TTM value through Dec 2025 reached $19.8 million, changed N/A, while the annual FY2025 figure was $22.6 million, 53.78% down from the prior year.
  • Depreciation & Amortization (CF) reached $4.3 million in Q4 2025 per CAI's latest filing, down from $6.4 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $10.5 million in Q3 2024 and bottomed at $4.3 million in Q4 2025.